Notice: CellAED ® is currently unapproved in all jurisdictions. This website may include information on products or therapies not approved for use in Australia or New Zealand; and/or information which is intended only for healthcare professionals. By proceeding, you acknowledge that Rapid Response Revival does not in any way adopt, endorse or promote the content of any website(s) accessed via this link. You should discuss any information you access with your healthcare professional, to obtain advice which is tailored to your circumstances and needs.
CellAED® in the Spotlight at Medica Dusseldorf 2018
Rapid Response Revival attracted significant attention at Medica 2018 medical trade show in Dusseldorf, Germany 12th – 15th November 2018. The company’s low cost, small and lightweight product CellAED® is a new kind of Automated External Defibrillator (AED), designed specifically for the home and personal markets.
Because of the word of mouth generated throughout the 21 halls of exhibitors and buyers at Medica, which is the world’s largest annual medical trade show, the Rapid Response Revival team of five were kept very busy across the four days of the event. At times, there were people waiting 3 and 4 deep to learn more about the CellAED®, and to pitch their credentials for distribution, investment, manufacturing, and priority purchase. New orders for hundreds of thousands of units are now being accepted, for delivery in 2019.
Rapid Response Revival CEO Leanne Knowles said of the event, ‘It’s obviously a big investment in time and resources for any Australian start-up to fly to Germany for a trade show. But we know we have something that the world needs. The educated buyer in the health and medical space understands the importance of the CellAED®, and some people told us that the major reason they came to Medica was to see this product. The buzz around our stand and the subsequent commitment to orders and distribution, is confirmation that we are officially in business. We now have hundreds of customers awaiting delivery in 2019.’
CellAED® is progressing through its CE Mark certification program and is on track to achieve that early 2019. Manufacturing arrangements in multiple global regions are being bedded down, maximising the skills, technology and know-how of specific operators. Rapid Response Revival Founder and Executive Chairman Donovan Casey said, ‘At Medica, we also connected with some manufacturers that are producing high tech materials that we didn’t know existed, and that will help us take the CellAED® to another level. We are now striking up some incredibly valuable new partnerships from being at Medica.’
Rapid Response Revival is a medical device and clinical data start-up, that is reinventing the global category for AEDs. While 70-80% of Sudden Cardiac Arrests (SCA) occur in the home, existing AEDs are expensive, heavy and cumbersome, making ownership beyond most people. CellAED® is a new kind of AED, designed specifically to meet the needs of the Personal & Home AED Markets. Technology has until now been a barrier to the creation of a miniature, mobile AED. Rapid Response Revival® has overcome these barriers. CellAED® is smaller, lighter, more affordable.
CellAED® is the solution, as it Enables & Empowers® Everyone, Everywhere® to dramatically improve the chances of survival for someone is Sudden Cardiac Arrest.
6 million people die each year from SCA. Think of someone from within your own circle of family and friends who might be saved in the future with the CellAED®. CellAED® is the logical evolution of the AED, and it will save many many lives.